Eli Book Value Per Share from 2010 to 2025

LLY Stock

USD 823.23 19.15 2.38%

Eli Lilly Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 6.21 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Eli Lilly and according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

10.87

Current Value

6.21

Quarterly Volatility

4.04338385

Credit Downgrade

Yuan Drop

Covid

Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 941.5 M, Interest Expense of 586.7 M or Total Revenue of 41.2 B, as well as many indicators such as Price To Sales Ratio of 14.52, Dividend Yield of 0.0085 or PTB Ratio of 45.99. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.

Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Eli Lilly and over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Eli Lilly's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 15.82 X

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Eli Book Value Per Share Regression Statistics

	Arithmetic Mean	10.47
	Geometric Mean	9.32
	Coefficient Of Variation	38.61
	Mean Deviation	3.07
	Median	11.95
	Standard Deviation	4.04
	Sample Variance	16.35
	Range	14.1527
	R-Value	(0.18)
	Mean Square Error	16.92
	R-Squared	0.03
	Significance	0.49
	Slope	(0.16)
	Total Sum of Squares	245.23

Eli Book Value Per Share History

	2025	6.21
	2024	10.87
	2023	12.08
	2022	11.95
	2021	10.09
	2020	6.42
	2019	2.9

Other Fundumenentals of Eli Lilly

Tangible Book Value Per Share

Eli Lilly Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.12	0.89	0.04	0.96	0.97	0.98	0.78	0.82	0.97	-0.34	-0.77	-0.77	0.9	0.56	0.85	0.65	0.85	-0.48	0.64	0.79	-0.16	0.84	-0.44	0.58	-0.7
Total Stockholder Equity	0.12		-0.24	0.97	-0.05	-0.13	0.1	-0.15	0.05	0.05	0.71	0.45	0.45	-0.31	-0.09	0.3	-0.04	-0.07	0.7	-0.49	-0.29	0.71	-0.05	0.22	0.27	0.12
Net Debt	0.89	-0.24		-0.34	0.96	0.95	0.85	0.86	0.82	0.94	-0.59	-0.94	-0.94	0.95	0.51	0.67	0.71	0.94	-0.68	0.78	0.84	-0.43	0.87	-0.69	0.59	-0.88
Retained Earnings	0.04	0.97	-0.34		-0.16	-0.2	0.03	-0.2	-0.05	-0.04	0.79	0.55	0.55	-0.37	-0.03	0.23	-0.07	-0.2	0.7	-0.54	-0.37	0.78	-0.15	0.35	0.11	0.26
Net Receivables	0.96	-0.05	0.96	-0.16		0.97	0.95	0.81	0.84	0.98	-0.51	-0.87	-0.87	0.94	0.48	0.78	0.64	0.92	-0.56	0.72	0.83	-0.32	0.88	-0.57	0.65	-0.8
Total Liab	0.97	-0.13	0.95	-0.2	0.97		0.95	0.83	0.8	0.96	-0.52	-0.88	-0.88	0.97	0.59	0.79	0.69	0.87	-0.67	0.78	0.88	-0.33	0.84	-0.51	0.53	-0.73
Total Current Assets	0.98	0.1	0.85	0.03	0.95	0.95		0.69	0.83	0.94	-0.34	-0.73	-0.73	0.88	0.5	0.82	0.59	0.79	-0.45	0.62	0.77	-0.16	0.86	-0.32	0.59	-0.63
Intangible Assets	0.78	-0.15	0.86	-0.2	0.81	0.83	0.69		0.52	0.82	-0.45	-0.81	-0.81	0.86	0.53	0.68	0.78	0.85	-0.71	0.76	0.76	-0.22	0.57	-0.73	0.36	-0.74
Short Term Debt	0.82	0.05	0.82	-0.05	0.84	0.8	0.83	0.52		0.86	-0.28	-0.64	-0.64	0.7	0.29	0.56	0.5	0.79	-0.25	0.39	0.55	-0.15	0.97	-0.41	0.74	-0.79
Accounts Payable	0.97	0.05	0.94	-0.04	0.98	0.96	0.94	0.82	0.86		-0.4	-0.81	-0.81	0.9	0.5	0.79	0.67	0.93	-0.49	0.64	0.77	-0.22	0.89	-0.58	0.66	-0.82
Short Term Investments	-0.34	0.71	-0.59	0.79	-0.51	-0.52	-0.34	-0.45	-0.28	-0.4		0.77	0.77	-0.66	-0.26	-0.21	-0.27	-0.44	0.75	-0.75	-0.69	0.88	-0.34	0.46	-0.18	0.4
Capital Stock	-0.77	0.45	-0.94	0.55	-0.87	-0.88	-0.73	-0.81	-0.64	-0.81	0.77		1.0	-0.94	-0.48	-0.59	-0.63	-0.85	0.82	-0.88	-0.91	0.66	-0.71	0.68	-0.45	0.75
Common Stock	-0.77	0.45	-0.94	0.55	-0.87	-0.88	-0.73	-0.81	-0.64	-0.81	0.77	1.0		-0.94	-0.48	-0.59	-0.63	-0.85	0.82	-0.88	-0.91	0.66	-0.71	0.68	-0.45	0.75
Long Term Debt	0.9	-0.31	0.95	-0.37	0.94	0.97	0.88	0.86	0.7	0.9	-0.66	-0.94	-0.94		0.6	0.72	0.7	0.85	-0.79	0.88	0.92	-0.49	0.78	-0.56	0.46	-0.71
Treasury Stock	0.56	-0.09	0.51	-0.03	0.48	0.59	0.5	0.53	0.29	0.5	-0.26	-0.48	-0.48	0.6		0.56	0.62	0.42	-0.54	0.57	0.59	-0.21	0.36	-0.17	0.11	-0.25
Property Plant Equipment	0.85	0.3	0.67	0.23	0.78	0.79	0.82	0.68	0.56	0.79	-0.21	-0.59	-0.59	0.72	0.56		0.74	0.68	-0.4	0.66	0.8	-0.04	0.58	-0.4	0.59	-0.5
Good Will	0.65	-0.04	0.71	-0.07	0.64	0.69	0.59	0.78	0.5	0.67	-0.27	-0.63	-0.63	0.7	0.62	0.74		0.69	-0.61	0.73	0.74	-0.18	0.58	-0.54	0.51	-0.61
Current Deferred Revenue	0.85	-0.07	0.94	-0.2	0.92	0.87	0.79	0.85	0.79	0.93	-0.44	-0.85	-0.85	0.85	0.42	0.68	0.69		-0.51	0.66	0.73	-0.27	0.82	-0.75	0.66	-0.92
Net Tangible Assets	-0.48	0.7	-0.68	0.7	-0.56	-0.67	-0.45	-0.71	-0.25	-0.49	0.75	0.82	0.82	-0.79	-0.54	-0.4	-0.61	-0.51		-0.92	-0.82	0.67	-0.37	0.48	-0.01	0.42
Long Term Debt Total	0.64	-0.49	0.78	-0.54	0.72	0.78	0.62	0.76	0.39	0.64	-0.75	-0.88	-0.88	0.88	0.57	0.66	0.73	0.66	-0.92		0.95	-0.61	0.5	-0.54	0.33	-0.51
Capital Surpluse	0.79	-0.29	0.84	-0.37	0.83	0.88	0.77	0.76	0.55	0.77	-0.69	-0.91	-0.91	0.92	0.59	0.8	0.74	0.73	-0.82	0.95		-0.58	0.63	-0.54	0.46	-0.58
Long Term Investments	-0.16	0.71	-0.43	0.78	-0.32	-0.33	-0.16	-0.22	-0.15	-0.22	0.88	0.66	0.66	-0.49	-0.21	-0.04	-0.18	-0.27	0.67	-0.61	-0.58		-0.24	0.34	-0.06	0.26
Short Long Term Debt	0.84	-0.05	0.87	-0.15	0.88	0.84	0.86	0.57	0.97	0.89	-0.34	-0.71	-0.71	0.78	0.36	0.58	0.58	0.82	-0.37	0.5	0.63	-0.24		-0.42	0.73	-0.81
Cash And Equivalents	-0.44	0.22	-0.69	0.35	-0.57	-0.51	-0.32	-0.73	-0.41	-0.58	0.46	0.68	0.68	-0.56	-0.17	-0.4	-0.54	-0.75	0.48	-0.54	-0.54	0.34	-0.42		-0.46	0.85
Net Invested Capital	0.58	0.27	0.59	0.11	0.65	0.53	0.59	0.36	0.74	0.66	-0.18	-0.45	-0.45	0.46	0.11	0.59	0.51	0.66	-0.01	0.33	0.46	-0.06	0.73	-0.46		-0.67
Net Working Capital	-0.7	0.12	-0.88	0.26	-0.8	-0.73	-0.63	-0.74	-0.79	-0.82	0.4	0.75	0.75	-0.71	-0.25	-0.5	-0.61	-0.92	0.42	-0.51	-0.58	0.26	-0.81	0.85	-0.67

Click cells to compare fundamentals

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	10.87	6.21
Tangible Book Value Per Share	(1.26)	(1.19)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC